GB9815871D0 - Novel compound - Google Patents

Novel compound

Info

Publication number
GB9815871D0
GB9815871D0 GBGB9815871.0A GB9815871A GB9815871D0 GB 9815871 D0 GB9815871 D0 GB 9815871D0 GB 9815871 A GB9815871 A GB 9815871A GB 9815871 D0 GB9815871 D0 GB 9815871D0
Authority
GB
United Kingdom
Prior art keywords
novel compound
novel
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9815871.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Laboratoires Pharmaceutiques
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Laboratoires Pharmaceutiques
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Laboratoires Pharmaceutiques, SmithKline Beecham Ltd filed Critical SmithKline Beecham Laboratoires Pharmaceutiques
Priority to GBGB9815871.0A priority Critical patent/GB9815871D0/en
Publication of GB9815871D0 publication Critical patent/GB9815871D0/en
Priority to MA25690A priority patent/MA26662A1/en
Priority to PE1999000726A priority patent/PE20000881A1/en
Priority to ARP990103577A priority patent/AR020614A1/en
Priority to IL14066499A priority patent/IL140664A0/en
Priority to TR2001/00207T priority patent/TR200100207T2/en
Priority to TR2001/00208T priority patent/TR200100208T2/en
Priority to DK99934911T priority patent/DK1098638T3/en
Priority to IL14074199A priority patent/IL140741A0/en
Priority to EP04077992A priority patent/EP1523980A3/en
Priority to EA200100165A priority patent/EA200100165A1/en
Priority to TW088112356A priority patent/TWI239836B/en
Priority to PL99345663A priority patent/PL345663A1/en
Priority to SI9930889T priority patent/SI1098638T1/en
Priority to CO99045729A priority patent/CO5060465A1/en
Priority to EA200100164A priority patent/EA004772B1/en
Priority to KR1020017000924A priority patent/KR20010079550A/en
Priority to CN99808983A priority patent/CN1310620A/en
Priority to KR1020017000925A priority patent/KR20010079551A/en
Priority to BR9912144-1A priority patent/BR9912144A/en
Priority to PT99934914T priority patent/PT1098639E/en
Priority to CA002338216A priority patent/CA2338216A1/en
Priority to CA002338211A priority patent/CA2338211A1/en
Priority to AU50535/99A priority patent/AU5053599A/en
Priority to OA1200100021A priority patent/OA11583A/en
Priority to CNB998089826A priority patent/CN1167416C/en
Priority to DK99934914T priority patent/DK1098639T3/en
Priority to IDW20010150A priority patent/ID26986A/en
Priority to SK101-2001A priority patent/SK1012001A3/en
Priority to PL99345627A priority patent/PL345627A1/en
Priority to DZ990154A priority patent/DZ2854A1/en
Priority to PT99934911T priority patent/PT1098638E/en
Priority to IDW20010151A priority patent/ID27850A/en
Priority to ES99934914T priority patent/ES2237929T3/en
Priority to JP2000560883A priority patent/JP2002521326A/en
Priority to NZ509175A priority patent/NZ509175A/en
Priority to APAP/P/2001/002033A priority patent/AP1416A/en
Priority to AT99934911T priority patent/ATE318588T1/en
Priority to EP04078537A priority patent/EP1516617A2/en
Priority to HU0103199A priority patent/HUP0103199A3/en
Priority to SK102-2001A priority patent/SK1022001A3/en
Priority to TW092103470A priority patent/TW200307532A/en
Priority to GCP1999211 priority patent/GC0000173A/en
Priority to SI9930772T priority patent/SI1098639T1/xx
Priority to EP99934914A priority patent/EP1098639B1/en
Priority to CZ2001250A priority patent/CZ2001250A3/en
Priority to AU50537/99A priority patent/AU5053799A/en
Priority to ES99934911T priority patent/ES2259839T3/en
Priority to JP2000560882A priority patent/JP2002521325A/en
Priority to PCT/GB1999/002361 priority patent/WO2000004890A1/en
Priority to DE69923687T priority patent/DE69923687T2/en
Priority to AT99934914T priority patent/ATE288746T1/en
Priority to APAP/P/2001/002036A priority patent/AP2001002036A0/en
Priority to OA1200100010A priority patent/OA11579A/en
Priority to DE69930125T priority patent/DE69930125T2/en
Priority to HU0103870A priority patent/HUP0103870A3/en
Priority to EP99934911A priority patent/EP1098638B1/en
Priority to PCT/GB1999/002358 priority patent/WO2000004889A1/en
Priority to BR9912117-4A priority patent/BR9912117A/en
Priority to ZA200100439A priority patent/ZA200100439B/en
Priority to ZA200100438A priority patent/ZA200100438B/en
Priority to NO20010292A priority patent/NO20010292L/en
Priority to NO20010293A priority patent/NO20010293L/en
Priority to BG105250A priority patent/BG105250A/en
Priority to BG105251A priority patent/BG105251A/en
Priority to HK01107620A priority patent/HK1037865A1/en
Priority to US10/072,098 priority patent/US20020099082A1/en
Priority to US10/290,596 priority patent/US20030069282A1/en
Priority to US10/348,456 priority patent/US6613785B2/en
Priority to US10/459,869 priority patent/US6699889B2/en
Priority to US10/725,667 priority patent/US20040110800A1/en
Priority to US10/797,841 priority patent/US20040254229A1/en
Priority to CY20061100616T priority patent/CY1106078T1/en
Ceased legal-status Critical Current

Links

GBGB9815871.0A 1998-07-21 1998-07-21 Novel compound Ceased GB9815871D0 (en)

Priority Applications (73)

Application Number Priority Date Filing Date Title
GBGB9815871.0A GB9815871D0 (en) 1998-07-21 1998-07-21 Novel compound
MA25690A MA26662A1 (en) 1998-07-21 1999-07-19 THIAZOLIDINEDIONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
PE1999000726A PE20000881A1 (en) 1998-07-21 1999-07-20 USE OF THIAZOLIDINDIONA AS A CARDIOPROTECTOR
ARP990103577A AR020614A1 (en) 1998-07-21 1999-07-21 NEW METHOD
IL14066499A IL140664A0 (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing apoptosis
TR2001/00207T TR200100207T2 (en) 1998-07-21 1999-07-21 The use of substance enhancing glucose uptake for the reduction of apoptosis
TR2001/00208T TR200100208T2 (en) 1998-07-21 1999-07-21 The use of a glucose uptake promoter in a structure to reduce post-ischemic damage in the heart.
DK99934911T DK1098638T3 (en) 1998-07-21 1999-07-21 Use of a glucose uptake enhancer to reduce post-ischemic lesion in the heart
IL14074199A IL140741A0 (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
EP04077992A EP1523980A3 (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
EA200100165A EA200100165A1 (en) 1998-07-21 1999-07-21 APPLICATION OF GLUCOSE CAPTURE AMPLIFIER TO REDUCE APOPTOSIS
TW088112356A TWI239836B (en) 1998-07-21 1999-07-21 A pharmaceutical composition for reducing post-ischaemic injury of the heart and/or improving the function recovery of the heart following myocardial ischaemia
PL99345663A PL345663A1 (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
SI9930889T SI1098638T1 (en) 1998-07-21 1999-07-21 Use of a glucose uptake enhancer for reducing post-ischemic injury of the heart
CO99045729A CO5060465A1 (en) 1998-07-21 1999-07-21 NEW METHOD
EA200100164A EA004772B1 (en) 1998-07-21 1999-07-21 Use of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]-thiazolidine-2,4-dione for reducing post-ischemic injury of the heart
KR1020017000924A KR20010079550A (en) 1998-07-21 1999-07-21 Use Of Glucose Uptake Enhancer for Reducing Post-ischemic Injury of the Heart
CN99808983A CN1310620A (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing apoptosis
KR1020017000925A KR20010079551A (en) 1998-07-21 1999-07-21 Use Of Glucose Uptake Enhancer for Reducing Apoptosis
BR9912144-1A BR9912144A (en) 1998-07-21 1999-07-21 Use of glucose absorption as a promoter to reduce post-ischemic heart damage
PT99934914T PT1098639E (en) 1998-07-21 1999-07-21 THE USE OF GLUCOSE CAPTURE INTENSIFIERS TO REDUCE APOPTOSIS
CA002338216A CA2338216A1 (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
CA002338211A CA2338211A1 (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing apoptosis
AU50535/99A AU5053599A (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
OA1200100021A OA11583A (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart.
CNB998089826A CN1167416C (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
DK99934914T DK1098639T3 (en) 1998-07-21 1999-07-21 Use of the glucose uptake enhancer rosiglitazone to reduce ischemia-induced apoptosis of pancreatic beta cells, endothelial cells, and neuronal cells
IDW20010150A ID26986A (en) 1998-07-21 1999-07-21 USE OF IMPROVING GLUCOSE TO REDUCE APOPTOSIS
SK101-2001A SK1012001A3 (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing apoptosis
PL99345627A PL345627A1 (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing apoptosis
DZ990154A DZ2854A1 (en) 1998-07-21 1999-07-21 Thiazolidinedione derivatives, pharmaceutical compositions containing them and their use.
PT99934911T PT1098638E (en) 1998-07-21 1999-07-21 USE OF GLUCOSE CAPTURE INTENSIFIER TO REDUCE POSSCHEMICAL HEART LESA
IDW20010151A ID27850A (en) 1998-07-21 1999-07-21 USE OF INCREASING RECEPTION OF GLUCOSE TO REDUCE HEART POST-ISKEMIA INJURY
ES99934914T ES2237929T3 (en) 1998-07-21 1999-07-21 USE OF THE ROSIGLITAZONA GLUCOSE ASSIMILATION ACTIVATOR TO REDUCE THE APOPTOSIS INDUCED BY ISCHEMIA OF BETA PANCREATIC CELLS, ENDOTELIAL CELLS AND NEURONAL CELLS.
JP2000560883A JP2002521326A (en) 1998-07-21 1999-07-21 Use of a glucose uptake enhancer to reduce apoptosis
NZ509175A NZ509175A (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing post- ischemic injury of the heart
APAP/P/2001/002033A AP1416A (en) 1998-07-21 1999-07-21 Uses of glucose uptake enhancer for reducing post-ischmemic injury of the heart.
AT99934911T ATE318588T1 (en) 1998-07-21 1999-07-21 USE OF A GLUCOSE UPtake ENHANCER TO REDUCE POST-SCHAEMIC HEART INJURY
EP04078537A EP1516617A2 (en) 1998-07-21 1999-07-21 Use of a thiazolidinedione for reducing apoptosis of pancreatic beta cells
HU0103199A HUP0103199A3 (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing apoptosis
SK102-2001A SK1022001A3 (en) 1998-07-21 1999-07-21 USE OF GLUCOSE UPTAKE ENHANCER FOR REDUCING POST-ISCHEMIC INJURYì (54) OF THE HEART
TW092103470A TW200307532A (en) 1998-07-21 1999-07-21 A pharmaceutical composition for reducing post-ischaemic injury of the heart and/or improving the functional recovery of the heart following myocardial ischaemia
GCP1999211 GC0000173A (en) 1998-07-21 1999-07-21 Glucose uptake enhancers for improving the functional recovery of the heart following myocardial ischaemia
SI9930772T SI1098639T1 (en) 1998-07-21 1999-07-21
EP99934914A EP1098639B1 (en) 1998-07-21 1999-07-21 Use of the glucose uptake enhancer rosiglitazone for reducing ischaemia-induced apoptosis of pancreatic beta cells, endothelial cells and neuronal cells
CZ2001250A CZ2001250A3 (en) 1998-07-21 1999-07-21 Medicament for reduction of post-ischaemic injury of the heart and/or improvement of heart recovery and pharmaceutical preparation containing glucose uptake enhancer
AU50537/99A AU5053799A (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing apoptosis
ES99934911T ES2259839T3 (en) 1998-07-21 1999-07-21 USE OF A GLUCOSE ABSORPTION ACTIVATOR TO REDUCE THE POSTISCHEMICAL INJURY OF THE HEART.
JP2000560882A JP2002521325A (en) 1998-07-21 1999-07-21 Use of a glucose uptake enhancer to reduce cardiac damage after ischemia
PCT/GB1999/002361 WO2000004890A1 (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing apoptosis
DE69923687T DE69923687T2 (en) 1998-07-21 1999-07-21 Use of the glucose uptake receptor rosiglitazone to reduce ischemia-induced apoptosis of pancreatic beta cells, endothelial cells and neuronal cells
AT99934914T ATE288746T1 (en) 1998-07-21 1999-07-21 USE OF THE GLUCOSE UPtake ENHANCER ROSIGLITAZONE TO REDUCE ISCHEMIA-INDUCED APOPTOSIS OF PANCREATIC BETA CELLS, ENDOTHELIAL CELLS AND NEURONAL CELLS
APAP/P/2001/002036A AP2001002036A0 (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing apoptosis.
OA1200100010A OA11579A (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing apoptosis.
DE69930125T DE69930125T2 (en) 1998-07-21 1999-07-21 Use of an enhancer of glucose uptake to reduce postischemic cardiac damage
HU0103870A HUP0103870A3 (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
EP99934911A EP1098638B1 (en) 1998-07-21 1999-07-21 Use of a glucose uptake enhancer for reducing post-ischemic injury of the heart
PCT/GB1999/002358 WO2000004889A1 (en) 1998-07-21 1999-07-21 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
BR9912117-4A BR9912117A (en) 1998-07-21 1999-07-21 Use of glucose uptake stimulator to reduce apoptosis
ZA200100439A ZA200100439B (en) 1998-07-21 2001-01-16 Use of glucose uptake enhancer for reducing postischemic injury of the heart.
ZA200100438A ZA200100438B (en) 1998-07-21 2001-01-16 Use of glucose uptake enhancer for reducing apoptosis.
NO20010292A NO20010292L (en) 1998-07-21 2001-01-18 Use of glucose uptake enhancer to reduce apoptosis
NO20010293A NO20010293L (en) 1998-07-21 2001-01-18 Use of glucose uptake enhancer to reduce post-ischemic heart damage
BG105250A BG105250A (en) 1998-07-21 2001-02-14 Means for reducing apoptosis
BG105251A BG105251A (en) 1998-07-21 2001-02-14 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
HK01107620A HK1037865A1 (en) 1998-07-21 2001-10-31 Use of the glucose uptake enhancer rosiglitazone for reducing ischaemia-induced apoptosis of pancreatic beta cells, endothelial cells and neuronal cells.
US10/072,098 US20020099082A1 (en) 1998-07-21 2002-02-07 Use of glucose uptake enhancer for reducing apoptosis
US10/290,596 US20030069282A1 (en) 1998-07-21 2002-11-08 Use of glucose uptake enhancer for reducing apoptosis
US10/348,456 US6613785B2 (en) 1998-07-21 2003-01-21 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
US10/459,869 US6699889B2 (en) 1998-07-21 2003-06-12 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
US10/725,667 US20040110800A1 (en) 1998-07-21 2003-12-02 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
US10/797,841 US20040254229A1 (en) 1998-07-21 2004-03-10 Use of glucose uptake enhancer for reducing apoptosis
CY20061100616T CY1106078T1 (en) 1998-07-21 2006-05-12 USE OF GLUCOSE UPTAKE ENHANCER TO REDUCE POST-ISCHEMIC HEART DAMAGE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9815871.0A GB9815871D0 (en) 1998-07-21 1998-07-21 Novel compound

Publications (1)

Publication Number Publication Date
GB9815871D0 true GB9815871D0 (en) 1998-09-16

Family

ID=10835913

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9815871.0A Ceased GB9815871D0 (en) 1998-07-21 1998-07-21 Novel compound

Country Status (2)

Country Link
GB (1) GB9815871D0 (en)
ZA (2) ZA200100438B (en)

Also Published As

Publication number Publication date
ZA200100439B (en) 2002-10-03
ZA200100438B (en) 2002-10-04

Similar Documents

Publication Publication Date Title
GB9801392D0 (en) Novel compounds
GB9920332D0 (en) Novel compound
GB9805348D0 (en) Compound
GB9827431D0 (en) Novel compound
GB9808268D0 (en) Compound
GB9808896D0 (en) Novel compound
GB9808894D0 (en) Novel compound
GB9823175D0 (en) Compound
GB9817338D0 (en) Novel compound
GB9827277D0 (en) Novel compound
GB9820404D0 (en) Novel compound
GB9817337D0 (en) Novel compound
GB9817323D0 (en) Novel compound
GB9815871D0 (en) Novel compound
GB9817310D0 (en) Novel compound
GB9817307D0 (en) Novel compound
GB9826172D0 (en) Novel compound
GB9821732D0 (en) Novel compound
GB9817321D0 (en) Novel compound
GB9823856D0 (en) Novel compound
GB9800317D0 (en) Novel compounds
GB9809836D0 (en) Novel compounds
GB9800324D0 (en) Novel compounds
GB9800337D0 (en) Novel compounds
GB9801882D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)